Harbour BioMed Receives Chinese Regulatory Approval of IND Application to Begin Seamless Phase 2/3 Clinical Trial of HBM9161 in Immune Thrombocytopenia Apr 15, 2020 Life Science
Healthcare Roundup – Teladoc services surged in Q1 due to COVID-19, Sonnet BioTherapeutics up 87% Apr 14, 2020 Life Science
Technology Roundup – Apple launches virus-tracking tool, Nvidia-Mellanox deal nears Chinese approval Apr 14, 2020 Technology
China’s Second Covid-19 Vaccine Is Set to Be World’s Third to Enter Clinical Trials Apr 14, 2020 Life Science
Healthcare Roundup – Feds turn on funding spigot with $30B, Study shows viability of saliva testing for COVID-19 Apr 13, 2020 Life Science
Technology Roundup – Amazon reopens nonessential shipments, Alibaba target raised on e-commerce recovery Apr 13, 2020 Technology
Healthcare Roundup –Fauci hopes to see steps to normalization by summer, Pfizer identifies lead COVID-19 candidate Apr 9, 2020 Life Science
Technology Roundup –Alibaba’s H2 trending better than feared, Apple’s U.S. iPhone sales take hit Apr 9, 2020 Technology
Walmart to Invest USD424.5 Million in Wuhan to Support City’s Economic Recovery Apr 9, 2020 Technology
Regeneron and Zai Lab Announce Regional Strategic Collaboration for REGN1979 (CD20xCD3 Bispecific Antibody) Apr 8, 2020 Life Science
Healthcare Roundup – Mylan to donate 10M doses of malaria drug, Feds award $489M ventilator contract to GM Apr 8, 2020 Life Science
Technology Roundup – LinkedIn makes ‘no layoffs’ pledge, Foxconn’s Wisconsin plant will make ventilators Apr 8, 2020 Technology
Ascentage Pharma Announces Approval for the Phase Ib/II Clinical Study of Bcl-2 Inhibitor APG-2575 for the Treatment of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in China Apr 8, 2020 Life Science
